About Biolidics
Biolidics is a company based in Singapore (Singapore) founded in 2009. It operates as a HealthTech. The company has 7 employees as of December 31, 2024. Biolidics offers products and services including ClearCell FX1 System. Biolidics operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Singapore, Singapore
- Employees 7 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Embracing Future Holdings Limited
-
Annual Revenue
$575.03 K (USD)183.03as on Dec 31, 2024
-
Net Profit
$-2.52 M (USD)-38.02as on Dec 31, 2024
-
EBITDA
$-2.33 M (USD)-130.31as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biolidics
Biolidics is a publicly listed company on the SGX with ticker symbol 8YY in Singapore, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biolidics
Biolidics offers a comprehensive portfolio of products and services, including ClearCell FX1 System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated system for cancer cell separation from blood.
Unlock access to complete
Unlock access to complete
Funding Insights of Biolidics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Biolidics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biolidics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biolidics Comparisons
Competitors of Biolidics
Biolidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biolidics
Frequently Asked Questions about Biolidics
When was Biolidics founded?
Biolidics was founded in 2009.
Where is Biolidics located?
Biolidics is headquartered in Singapore, Singapore.
How many employees does Biolidics have?
As of Dec 31, 2024, the latest employee count at Biolidics is 7.
What is the annual revenue of Biolidics?
Annual revenue of Biolidics is $575.03K as on Dec 31, 2024.
What does Biolidics do?
Biolidics Limited is focused on developing innovative diagnostic solutions to reduce healthcare costs and improve clinical outcomes. A portfolio of medical devices, including the ClearCell FX1 System for cancer cell separation, is offered. Additionally, technology-enabled lifestyle businesses such as Multi-Channel Networks, live streaming e-commerce platforms, and Esports-related ventures are being explored for long-term growth and diversification.
Who are the top competitors of Biolidics?
Biolidics's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
What products or services does Biolidics offer?
Biolidics offers ClearCell FX1 System.
Is Biolidics publicly traded?
Yes, Biolidics is publicly traded on SGX under the ticker symbol 8YY.
What is Biolidics's ticker symbol?
The ticker symbol of Biolidics is 8YY on SGX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.